Integrated Biomolecule Corporation

Analytical services in a GLP/GMP environment for both large and small molecules. Methods development & validation, advanced analytical characterization, pk/pd, biomarker discovery, stability & release assays

Activity:

- Contract Research
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Diagnostics
- FP (finished products)
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Proteins

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Respiratory Medicine
- Stroke
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe

c. Countries active: United States, Belgium, France

Corporate data:

Number of Employees: 12

Turnover:

Amount:	Year:	Currency:
3 million	2006	US Dollar

Year founded: 1992